Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis in Addition to Prednisolon Therapy

NCT02326103 is registered in ClinicalTrials.gov with University of Helsinki as lead sponsor.

NCT NCT02326103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis in Addition to Prednisolon Therapy
Lead sponsor
University of Helsinki
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2015
Completion date
January 31, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic cirrhosis, alcoholic hepatitis